Sonomax Hearing Healthcare to report on financing arrangement with Benvest New Look Income Fund

NewsGuard 100/100 Score

Sonomax Hearing Healthcare Inc. (SHH:TSX Venture) announces that with reference to its previously-announced conference call scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the results of Sonomax's initiative to license its new Self-Fit(TM) headset technology at the recent Consumer Electronics Show in Las Vegas, and the company's outlook for 2010 and beyond, the company will also report on the $1.74 million non-dilutive financing arrangement that it has entered into with Benvest New Look Income Fund (BCI:UN: TSX).

All interested parties are invited to participate by dialling toll-free 1-866-365-1119 (North America only) and 1-416-849-7329 Outside North America. You will be put on hold until the conference call begins.

Management's report will be followed by a Question and Answer period. Management notes that Sonomax is bound by a number of Non-Disclosure Agreements that were entered into at or before the CES, and that consequently, some of the information that is communicated will need to remain generic. We trust investors will understand the sensitive nature of our licensing business model.

A PowerPoint Presentation will be available for download on Thursday February 4th at 9:00AM EST in the Investor Relations section of the Sonomax website http://sonomax.com/investor-relations/investing-in-sonomax.html. A copy of live Web cast will be available following the conference call in the same section.

Sonomax also announces that its detailed management proxy circular describing the proposed arrangement with Benvest New Look Income Fund is being mailed to Sonomax shareholders and holders of Sonomax's convertible promissory notes. The management proxy circular is available on SEDAR at www.sedar.com and will also be available on Sonomax's website at www.sonomax.com.

Source: SONOMAX HEARING HEALTHCARE INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI technologies can accurately identify cases of healthcare-associated infections